These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9387497)

  • 21. Distortion product otoacoustic emissions in tinnitus patients.
    Onishi ET; Fukuda Y; Suzuki FA
    Int Tinnitus J; 2004; 10(1):13-6. PubMed ID: 15379342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of sensorineural hearing loss in childhood].
    Luo R; Mai J; Chen Q; Yang S; Zhong J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):346-51. PubMed ID: 12761942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical study of the efferent auditory system in patients with normal hearing who have acute tinnitus.
    Riga M; Papadas T; Werner JA; Dalchow CV
    Otol Neurotol; 2007 Feb; 28(2):185-90. PubMed ID: 17255885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3-dimensional representation of transient evoked otoacoustic emissions].
    Breuer T; Herberhold C; Rödel R
    Laryngorhinootologie; 1994 Mar; 73(3):113-7. PubMed ID: 8172628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Auditory neuropathy].
    Liang F; Liu C; Liu B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 34(6):350-2. PubMed ID: 12764843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Otoacoustic emissions and medial olivocochlear suppression during auditory recovery from acoustic trauma in humans.
    Veuillet E; Martin V; Suc B; Vesson JF; Morgon A; Collet L
    Acta Otolaryngol; 2001 Jan; 121(2):278-83. PubMed ID: 11349796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related declines in distortion product otoacoustic emissions utilizing pure tone contralateral stimulation in CBA/CaJ mice.
    Varghese GI; Zhu X; Frisina RD
    Hear Res; 2005 Nov; 209(1-2):60-7. PubMed ID: 16061336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the noise-protective action of the olivocochlear efferents in humans.
    Wolpert S; Heyd A; Wagner W
    Audiol Neurootol; 2014; 19(1):31-40. PubMed ID: 24281009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of hyperacusis in sensorineural tinnitus patients with normal audiological assessment.
    de Magalhães SL; Fukuda Y; Liriano RI; Chami FA; Barros F; Diniz FL
    Int Tinnitus J; 2003; 9(2):79-83. PubMed ID: 15106278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
    Riga M; Korres S; Psarommatis I; Varvutsi M; Giotakis I; Papadas T; Ferekidis E; Apostolopoulos N
    Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of 100Hz amplitude modulation on the human medial olivocochlear reflex.
    Boothalingam S; Purcell D; Scollie S
    Neurosci Lett; 2014 Sep; 580():56-61. PubMed ID: 25102324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The assessment of olivocochlear function in neonates with real-time distortion product otoacoustic emissions.
    James AL
    Laryngoscope; 2011 Jan; 121(1):202-13. PubMed ID: 21181985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of otoacoustic emissions in screening and evaluation of noise damage.
    Prasher D; Sułkowski W
    Int J Occup Med Environ Health; 1999; 12(2):183-92. PubMed ID: 10465908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Otoacoustic emissions in patients with hypotension.
    Balatsouras DG; Korres S; Simaskos N; Kandiloros D; Ferekidis E; Economou C
    J Laryngol Otol; 2003 Apr; 117(4):265-9. PubMed ID: 12816214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Otoacoustic emissions, ear fullness and tinnitus in the recovery course of sudden deafness.
    Ishida IM; Sugiura M; Teranishi M; Katayama N; Nakashima T
    Auris Nasus Larynx; 2008 Mar; 35(1):41-6. PubMed ID: 17904320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Otoacoustic emissions in patients with retrocochlear dysfunction: a report of five cases.
    Ried EU; Ried EG; Avilés M
    Ear Nose Throat J; 2000 Jun; 79(6):438, 441-4, 446. PubMed ID: 10893834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contralateral suppression of distortion product otoacoustic emissions and the middle-ear muscle reflex in human ears.
    Sun XM
    Hear Res; 2008 Mar; 237(1-2):66-75. PubMed ID: 18258398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volterra Slice otoacoustic emissions recorded using maximum length sequences from patients with sensorineural hearing loss.
    de Boer J; Thornton AR
    Hear Res; 2006 Sep; 219(1-2):121-36. PubMed ID: 16887305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the neurobiology of hearing disorders: recent developments regarding the basis of tinnitus and hyperacusis.
    Knipper M; Van Dijk P; Nunes I; Rüttiger L; Zimmermann U
    Prog Neurobiol; 2013 Dec; 111():17-33. PubMed ID: 24012803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The First Jerger Lecture. Contralateral suppression of otoacoustic emissions: an index of the function of the medial olivocochlear system.
    Berlin CI; Hood LJ; Hurley A; Wen H
    Otolaryngol Head Neck Surg; 1994 Jan; 110(1):3-21. PubMed ID: 8290299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.